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11. Introduction 
An increase in the concentration of ionized Ca’+ in 
the cytosol of the P-cell is thought o be a controlling 
factor in stimulus-secretion coupling of glucose- 
induced insulin release [l-4]. Such an increase could 
result from a change in the distribution of celhdar cal- 
cium or from increased uptake of CaZ+ from the extra- 
cellular fluid or both. Both in vivo [5] and in vitro 
[l-4] a constant increase of the glucose concentration 
results in a spike-like first phase and a progressively 
rising second phase of insulin release. Presence of extra- 
cellular Ca2* has been thought necessary for both 
phases, since glucose does not stimulate insulin 
release after exposure to Ca2*deprived media [3,6]. 
Exposure to such media, however, does not only 
minimize the effects of extracellular Ca2+; it also 
decreases cellular calcium content [3,6] which may 
make it impossible to distinguish between effects 
of intra- or extracellular Ca2+ [7]. Therefore we inves- 
tigated whether glucose can utilize cellular calcium to 
cause insulin release in Ca” depleted medium. Since in 
other cells, the inward Na* gradient is involved in the 
extrusion of Ca*+ from the cell [8,9], conditions which 
decrease the Na’ gradient were imposed. These were 
the application of ouabain and the removal of extra- 
cellular K’ to inhibit Na/K ATPase [ 10,l I]. While 
Ca2+ removal at the time of glucose stimulation 
markedly reduced insulin release, this reduction was 
completely overcome during first phase and partially 
during second phase if Na/K ATPase was ~hibited 
when glucose was applied. 
2. Materials and methods 
Collagenase-isolated rat islets [ I] were maintained 
for 2 days in tissue culture medium 199 at 8.3 mM 
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glucose [lj6]. Thereafter, 40 islets per chamber were 
perifused as described [1,6]. The chamber volume 
was 70 pl and the flow rate 1.2 ml/min, the turnover 
was 17 chamber volumes per min. Standard perifusion 
buffer contained 1 .O mM CaClz. Ca*+deprived 
medium was prepared without the addition of CaC12. 
Its Ca” concentration was 14.0 + 1 .l FM (n = 3) as 
determined by atomic ab~rption spectrophotometry. 
When the perifusate was changed to Ca2’deprived 
medium, the measured Ca” concentration decreased 
from 1 mM to basal values (14.6 + 2.0 PM, n = 5) in 
the sample collected during the 2nd min. Assuming 
an exponential decay curve for the decrease, it can 
be calculated from the measured Ca2+ concentration 
over the first minute (63.8 f 2.0 PM, n = 5) that the 
concentration surrounding the islets was less than 
25 E.IM 15 s after the change. Insulin was determined 
by radioimmunoassay [ 121 using a rat standard. 
The sources of the materials have been described 
[1,6] except for ouabain (Merck, Darmstadt, FRG). 
Data are given as means + SEM and were analysed by 
Student’s unpaired t-test. 
3. Results 
At 1 mM Ca2+, 16.7 mM glucose licited a biphasic 
insuLin release (f&l). One minute after high glucose 
had reached the islets, insulin release started to rise 
to a peak which was reached at 2-3 min. A nadir at 
5-7 min was followed by an increasing second phase. 
0.1 mM ouabain added at the time of glucose stimu- 
lation had no significant effect on insulin release at 
either low or high glucose. This finding is similar to 
that described by others for the same concentration 
of ouabain [ 131, When Cat+ was removed simulta- 
neously with glucose stimulation, insulin release was 
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Fig.1. Effect of 0.1 mM ouabain on basal and glucose- 
induced insulin release. Following 2 days in tissue culture, 
islets were perifused with a Krebs-Ringer bicarbonate buffer 
containing 1 mM Ca**, 0.5% bovine serum albumin and 2.8 mM 
glucose 111. After 46 min two groups of islets were stimu- 
lated for 44 min with 16.7 mM glucose. 0.1 mM ouabain 
was added after 46 mm to buffer containing either 2.8 or 
16.7 mM glucose. Numbers of observ&tions in parentheses. 
G, glucose. Values are presented as mean * SEM. 
markediy inhibited during both phases (fig.2). Addi- 
tion of 0.1 mM ouabain together with high glucose 
at the time of Ca2+ removal, greatly enhanced insulin 
release over both phases. During first phase (first 5 min) 
the inhibitory effect of Ca2+ removal was completely 
overcome whole second phase was restored to 43% of 
release at 1 mM Ca2+ (taking’inte~ated insulin release” 
above baseline). Ca2+ removal at 2.8 mM glucose 
throughout did not affect insulin release (fig.2). To 
exclude that the smah amount of extracellular Ca’+ 
present could have contributed to the restoration of 
insulin release of ouabain, six experiments were per- 
formed with the addition of 0.1 mM EGTA to the 
Ca2+-deprived medium. This did not signific~tly 
affect the restoration of ~uco~-st~ulated insulin 
release by ouabain (results not included). 
To see whether these marked effects of ouabain 
in the absence of extracellular Ca2+ were indeed due 
to its known inhibitory effect on the Na-pump, 
another condition which inhibits this pump was 
chosen, namely exposure to a medium prepared 
without K’ (fig.3). K’deprivation at the time of 
glucose stimulation and Ca2+ removal gave similar 
results asthose described for 0.1 mM ouabain. The 
inhibition of insulin release in the absence of Ca2+ 
was completely overcome during first phase; second 
phase was enhanced to 36% of insulin release at nor- 
mal Ca (integrated insulin above baseline). 
4. Discussion 
The presence of a Na’ pump in islets has been 
inferred from studies on ionic fluxes ]14,15] and 
electrophysiological findings [ 161. In addition, an 
enzyme with Na/K ATPase activity was found in rat 
islet homogenates [ 10,111. Ouabain, in a dose similar 
to the one used here, inhibited this enzyme [ IO,1 I]_ 
ge_p-iJ Ca** removal 
0’. * I 
LO 50 60 70 80 90 
minutes 
Fig.2. Effect of 0.1 mM ouabain on glucose-induced insulin 
release in Ca2* deprived medium. Islets were perifused for 
46 min with 2.8 mM glucose and 1 mM Ca” and then stimu- 
lated for 44 min with 16.7 mM glucose. When islets were 
exposed to Ca”* deprived medium (14 PM) with or without 
0.1 mM ouabain, this was applied after 46 min. A control 
grouponly subjected to Ca*+ removal after 46 min is included 
(lower shaded area). G, glucose. 
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Fig.3. Effect of K+ removal on glucose-induced insulin release 
in Ca’+ deprived medium. Islets were perifused for 46 min 
with 2.8 mM glucose and 1 mM Caa+ and then stimulated for 
44 min with 16.7 mM glucose. When islets were exposed to 
Ca2’ deprived medium, with or without K* removal, this was 
applied after 46 min. A control group onIy subjected to 
Ca’+ removal after 46 min is included (lower shaded area). 
K+deprived medium was prepared by replacing KCL and 
KH,F’O, by the equivalent sodium salt. G, glucose. 
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With respect o insulin release, ouabain at high glu- 
cose concentrations was generally not found to 
enhance insulin release [13,17]. At low glucose, 
varying results have been obtained epending on the 
pancreatic preparation and the dose employed 
([13,17,18], and refs. cited in [17]). 
The failure of ouabain to alter glucose-stimulated 
insulin release at normal Ca2+ contrasts markedly 
with its action in Ca2+-deprived media. In seeking an 
explanation for this finding the effects of glucose on 
Ca2+ handling by islets have to be considered. Apart 
from stimulating Ca2* uptake [l-4], glucose has been 
shown to inhibit Ca2* efflux [2,6] and both mecha- 
nisms could increase cytosol Ca2+. It is likely that a 
Na/Ca exchange takes place at the plasma membrane 
[ 1,18-201 like in other tissues [8,9}. Thus, the 
inward Na+ gradient, which is maintained by the 
Nd pump, permits the extrusion of CaZ+ against i s 
inwardly favorable lectrochemical gradient. There 
is evidence that glucose xerts its inhibitory effect 
on Ca2+ efflux.by interfering with Na/Ca exchange 
119,201. This action of glucose is not likely to occur 
via the Na-pump, since glucose and ouabain have 
opposite ffects on Na’ and K* handling in islets 
[14,15]. 
When the Ca2+ gradient is decreased by removal 
of extracellular Ca2+ (fg2), the balance between the 
Na+ and the Ca2’ gradient is disturbed. Since the Na’ 
content, and thus most likely the Na’ gradient, 
remains unaltered by Ca2+ removal [141, an increase 
in Ca2+ efflux should be expected. This has been 
demonstrated for 45Ca2+ efflux from preloaded islets 
[21]. Likewise, in the islet perifusion system used 
here, Ca2+ removal also caused arapid increase of 
45Ca2+ efflux from preloaded islets with a peak in the 
first min (results not shown). Therefore, Ca2+ removal 
will counteract the inhibitory effect of glucose on 
Ca2+ efflux (which would normally contribute to 
increase cytosol Ca*). When the Na’ pump is inhib- 
ited by ouabain or K’ omission, the Na+ gradient is 
reduced [141 and therefore the driving force for the 
coupled Ca2* efflux. A decrease of the sodium gra- 
dient has been shown to increase the 45calcium con- 
tent in isolated islets [18,22] which can be attributed 
to inhibition of Ca2+ efflux, since Ca** influx rates 
were not changed [22]. The expected inhibitory 
effect of ouabain on Ca2* efflux [20] may act syner- 
gistically with that due to glucose and outweigh the 
impact of Ca2” removal. This could, therefore, 
explain the restoration of insulin release (figs.2 and 3), 
if ouabain has a rapid onset of action. An onset of 
less than 1 min has indeed been shown in electro- 
physiological experiments for the depolarizing effect 
of both ouabain and K’ removal [161. Thus, the pre- 
sence of ouabain could allow glucose to raise cytosol 
Ca2’ high enough by the use of cellular calcium to 
account for a normal first phase of insulin release in 
spite of the absence of extracellular Ca2*. An addi- 
tional effect of increased intra~e~ular Na’ could be 
the mob~~ation of stored calcium [ 181. 
The finding that first phase is restored fully and 
second phase only partially is similar to results 
obtained when verapamil was used to block Ca2+ 
uptake via the voltage-dependent Ca2+ channel [I]. 
5 t.lM verapamil, which totally blocked glucose- 
stimulated Ca*+ uptake over the first phase, had no 
effect on insulin release during this period, but sec- 
ond phase was inhibited by 55%. Comparable findings 
were obtained from islets with increased calcium 
stored perifused at low extracellular Ca2* [23]. 
The results presented here demonstrate hat extra- 
cellular calcium is not an absolute requirement for 
the stimulation of insulin release. Glucose appears to 
use cellular Ca2+ to generate first phase [24], whereas 
both a cellular source of Ca2+ and increased influx of 
Ca*+ from the extracellular fluid contribute to the 
full development of second phase. ~r~gements in 
islet Ca2+ handling appear to play a role in the defec- 
tive glucose-stimulated insulin release of two diabetic 
animal syndromes [25,26] and in particular the 
mechanism(s) bywhich glucose utilises cellular 
calcium. 
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